Ovarian Preservation in Grade 2 or 3 Endometrial Cancer with Dimitrios Nasioudis
In this episode of the IJGC podcast, Editor-in-Ch…
BMJ talk medicine · BMJ Group
November 2, 202226m 16s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Dimitrios Nasioudis to discuss ovarian preservation in grade 2 or 3 endometrial cancer. Dr. Nasioudis is a Gynecologic Oncology Fellow at the University of Pennsylvania. His current research focuses on translational therapeutics and population-based research.
Highlights:
- For premenopausal patients with endometrial cancer, ovarian preservation is not associated with worse oncologic outcomes for those with grade 1 tumors. However, safety of ovarian preservation for grade 2 or 3 tumors is not established.
- Ovarian preservation was not associated with worse overall survival for patients with grade 2 or 3 endometrioid tumors.
-Ovarian preservation may be considered for carefully selected patients with grade 2 tumors.